<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

Dr John Corboy: Why Disease-Modifying Therapy Efficacy Varies With Age

Default sub title

minute read

Immunopathology changes with age, so older individuals with multiple sclerosis need medications that focus on effects inside the nervous system, explained John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine, and co-director of the Rocky Mountain MS Center at Anschutz Medical Campus.

Topics: Press Coverage

Related Stories